Trending Now
Why Russia’s Move is the Perfect Wake-Up Call for Green Energy...
Stocks are on sale and commodities are going through the roof as Russian forces cross into Ukraine and begin to excise the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BioLineRx Ltd. (NASDAQ: BLRX) Completes pre-NDA meeting on Motixafortide as a...
BioLineRx Ltd. (NASDAQ: BLRX) has announced the completion of a successful pre-NDA (New Drug Application) meeting with the US FDA about Motixafortide as a...
MAKE IT MODERN
LATEST REVIEWS
Black Diamond Therapeutics Inc. (NASDAQ:BDTX) Announces Fast Track Designation to BDTX-189...
There are hundreds of adult patients under the affliction of solid tumors harboring an allosteric HER2 mutation or an EGFR or HER2 exon 20...
MAKE IT MODERN
PERFORMANCE TRAINING
Aileron Therapeutics Inc (NASDAQ:ALRN) Raises $10.3 Million: Develops Innovative Medicine To Safeguard Cancer Patients...
Aileron Therapeutics Inc (NASDAQ:ALRN) develops innovative chemoprotective medicine to safeguard patients from side effects and toxicities induced by chemotherapy.
CEO of Aileron, Manuel Aivado, said...
Corcept Therapeutics (NASDAQ:CORT) Commences Enrolment In GRATITUDE II Trial For Miricorilant On Treatment of...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has enrolled the first subject in its GRATITUDE II Phase 2 double-blind, randomized, placebo-controlled study of miricorilant in obese patients...
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Presents Safety and Efficacy Data From Studies Evaluating ORLADEYO...
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) has released its latest long-term safety and efficacy data from the trials studying once-daily, oral ORLADEYO (berotralstat) for prophylactic...
Kezar Life Sciences Inc. (NASDAQ: KZR) Announces Preliminary Second Part OF MISSION Clinical Study...
Kezar Life Sciences Inc. (NASDAQ: KZR) has announced preliminary results from the second portion of the MISSION clinical study evaluating KZR-616 in patients having...
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates Of Flotetuzumab and...
MacroGenics Inc. (NASDAQ:MGNX) has reported its Q3 2020 financial results and provided its corporate progress update.
MacroGenics advancing three programs
Scott Koenig, the company's CEO...
MAKE IT MODERN
